UK
Healthtech

CoMind

Year Backed:
2021
Stage:
Growth

CoMind is revolutionising brain monitoring and treatment by delivering non-invasive, AI-driven neurotechnology that provides a multidimensional view of brain activity using light. Their groundbreaking solutions empower clinicians with real-time, actionable insights to enhance patient safety, improve outcomes, and transform care across intensive care, surgeries, and emergency settings.

Founders

James Dacombe

James Dacombe

CEO, Founder
Christina Franzeskides

Christina Franzeskides

COO, Co-Founder